Skip to main content
Caplight Logo









GlucoModicum

GlucoModicum

Private
HelsinkiHealthcare & Life Scienceshttps://glucomodicum.com/

Last Round

VC Round

Jun 17, 2024

Total Funding Raised

$7.3M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

GlucoModicum is a medical devices company that develops needle-free, continuous glucose monitoring technology using proprietary magnetohydrodynamic (MHD) fluid sampling.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors

Business Model

B2C

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

non-invasive glucose monitoringneedle-free glucose monitorcontinuous glucose monitorCGMmagnetohydrodynamic technologyMHDdiabetes managementmedical devicewearable health monitorblood glucose testingdigital healthhealth IoTsmart glucose sensor

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GlucoModicum Comparables

Compare GlucoModicum with similar companies based on industry and business-model similarity.

GlucoModicum comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DiaMonTech AG
89%
HAGAR N.I.G.
87%
Afon Technology
86%

GlucoModicum Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 17, 2024
VC RoundMar 1, 2022
GrantFeb 1, 2022
VC RoundOct 15, 2021
GrantJun 16, 2021
Grant
Jan 15, 2020

Key People

Founding team and executive leadership

Alejandro García Pérez

Chief Technology Officer Co-Founder

Founding Team

GlucoModicum Investors

Notable investors and investment history

GlucoModicum investors
InvestorRounds
European Innovation Council FundGrant, VC Round
Business FinlandGrant, Seed
University of HelsinkiPre Seed
Åbo Akademi UniversityPre Seed, Seed
EIC FundVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 29, 2026

    Monthly visitors increased 174% MoM, reaching 1.3K.

  • Jun 17, 2024

    LähiTapiola participated in the VC Round.

GlucoModicum Filings

Explore SEC and related filing metadata, where available.

GlucoModicum filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about GlucoModicum's valuation, stock price, and market status.

Is GlucoModicum a public or private company?

GlucoModicum is a private company.

What is the current stock price of GlucoModicum?

GlucoModicum is a private company with no public stock price. No recent secondary market data is available.

How much is GlucoModicum worth (valuation)?

Valuation information for GlucoModicum is not publicly available.

Can I buy GlucoModicum stock?

GlucoModicum shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was GlucoModicum's last funding round?

GlucoModicum's most recent funding round was VC Round on June 17, 2024.

Who are the main investors in GlucoModicum?

Key investors in GlucoModicum include EIC Fund.

Will GlucoModicum IPO soon?

No public IPO plans have been announced for GlucoModicum.

How can I track GlucoModicum secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GlucoModicum's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHelsinki
Employee Range38
Year Founded2018
Last FundingJun 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?